Opportunity Information: Apply for PAR 19 208

The National Institutes of Health (NIH), through the National Institute of General Medical Sciences (NIGMS), offered this limited-competition R24 grant opportunity to keep certain high-value, community-wide scientific resources running after their original NIGMS funding mechanism could no longer support them. The core idea is continuity: these are "legacy" resources that came out of NIGMS-supported research activities, are strongly aligned with the NIGMS mission, and are widely used (or clearly needed) by the NIGMS research community. The program is meant to prevent the loss of essential infrastructure that researchers rely on, especially when there is no obvious alternative NIH institute/center program that can pick up support and when the resource is not yet able to sustain itself through fees, subscriptions, institutional support, or commercialization.

A key feature of this announcement is how NIGMS defines a "resource." It is explicitly non-hypothesis-driven and made available to any qualified investigator. The resource provides broadly useful outputs such as datasets, materials, tools, or services that help researchers make progress faster, with higher quality, and at lower cost than they could without the resource. In practice, this type of resource could include shared data repositories, widely used research tools or platforms, curated community databases, distribution services for materials, or other infrastructure that many labs depend on. What this program does not support is the creation of brand-new resources; it is designed only for continuation of existing, NIGMS-sponsored legacy resources that have reached a funding transition point.

The allowable scope is maintenance-only. Applicants are expected to request support for activities that keep the resource operational and reliable, such as curation, updating, user support, quality assurance, documentation, basic engineering or upkeep, and other operational functions required for continuity. The opportunity is not intended to fund new research aims or hypothesis-driven studies, and it is also labeled "Clinical Trial Not Allowed," meaning applicants should not propose clinical trials under this mechanism. The emphasis is on sustaining community access and functionality rather than expanding into new lines of scientific investigation.

Another central expectation is that applicants use this support period to implement a realistic transition plan toward a more permanent support model. NIGMS allows up to three years of funding under this initiative, and that time is framed as a bridge while the resource moves toward longer-term stability. Examples of longer-term stability could include institutional commitment, consortium or society support, cost-recovery models, integration into other sustained infrastructure programs, or other durable funding strategies. The underlying message is that this award is time-limited and intended to facilitate a responsible handoff to a sustainable endpoint rather than indefinite dependence on this bridge mechanism.

Eligibility is broad across many U.S.-based organization types, including state, county, city/township, and special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other eligible entities. The announcement also highlights additional categories often emphasized for inclusive participation, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based/community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it restricts non-U.S. applicants: non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, although "foreign components" (as NIH defines them in the NIH Grants Policy Statement) are allowed, which can matter for resources that have legitimate international collaborations or dependencies while still being led by an eligible U.S. applicant organization.

Administratively, this is an NIH discretionary grant opportunity in the health category with CFDA number 93.859, and it is identified as PAR-19-208. The opportunity was created on March 4, 2019, and listed an original closing date of June 14, 2019. An award ceiling and expected number of awards are not specified in the provided source details, which is common for some NIH program announcements where the final number and size of awards depend on application quality, program priorities, and available funds.

In summary, this R24 limited-competition program was a targeted bridge to preserve vital NIGMS-associated community resources that would otherwise be at risk when their original funding mechanism ended. It focuses on keeping proven, widely valuable scientific resources available and functional for the broader research community, funding only maintenance and operations (not new research), and requiring a credible plan to transition the resource toward a stable, long-term support model within a three-year window.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
  • This funding opportunity was created on 2019-03-04.
  • Applicants must submit their applications by 2019-06-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 19 208

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this NIH/NIGMS R24 opportunity intended to do?

This limited-competition R24 opportunity (PAR-19-208) is designed to keep certain high-value, community-wide scientific resources running after their original NIGMS funding mechanism can no longer support them. The main goal is continuity for "legacy" resources that are strongly aligned with the NIGMS mission and are widely used (or clearly needed) by the NIGMS research community.

What does NIGMS mean by a "legacy" resource?

In this announcement, a legacy resource is an existing scientific resource that grew out of NIGMS-supported research activities and has reached a transition point where the original NIGMS support mechanism is ending or no longer appropriate. The program is intended to prevent loss of infrastructure that the community depends on.

Does this program support creating brand-new resources?

No. This opportunity does not support the creation of brand-new resources. It is specifically for continuation of existing, NIGMS-sponsored legacy resources that need bridge support to remain available to the community.

How does NIGMS define a "resource" for this program?

NIGMS defines a resource as explicitly non-hypothesis-driven and made available to any qualified investigator. It provides broadly useful outputs such as datasets, materials, tools, or services that help researchers move faster, improve quality, and reduce costs compared to working without the resource.

What are examples of resources that might fit this program?

Examples described in the opportunity include shared data repositories, widely used research tools or platforms, curated community databases, distribution services for materials, and other infrastructure relied upon by many labs.

What is the allowable scope of work under this R24?

The scope is maintenance-only. Supported activities are those required to keep the resource operational, reliable, and accessible, such as curation, updating, user support, quality assurance, documentation, and basic engineering/upkeep needed for continuity.

Can applicants propose new research aims or hypothesis-driven studies?

No. The opportunity is not intended to fund new research aims or hypothesis-driven studies. The emphasis is on sustaining community access and functionality of an existing resource.

Are clinical trials allowed under this funding opportunity?

No. The announcement is labeled "Clinical Trial Not Allowed," meaning clinical trials should not be proposed under this mechanism.

How long can NIH/NIGMS support a resource under this initiative?

NIGMS allows up to three years of funding under this initiative. This period is positioned as a bridge to maintain operations while the resource transitions to a more permanent support model.

Is a long-term sustainability plan required?

Yes. A central expectation is that applicants use the bridge period to implement a realistic transition plan toward a stable, longer-term support model, rather than relying on this mechanism indefinitely.

What kinds of longer-term support models does NIGMS expect resources to transition to?

The announcement gives examples such as institutional commitment, consortium or society support, cost-recovery models (fees/subscriptions), integration into other sustained infrastructure programs, or other durable funding strategies.

Why does NIGMS offer this as a bridge rather than ongoing support?

The program is explicitly time-limited and is meant to prevent sudden loss of essential infrastructure while encouraging a responsible handoff to a sustainable endpoint. It is used when the resource is not yet able to fully sustain itself and when there is no obvious alternative NIH institute/center program to pick up support.

Who is eligible to apply?

Eligibility is broad across many U.S.-based organization types. Examples listed include state/county/city/special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses) and small businesses; and other eligible entities.

Are specific institution types encouraged or highlighted?

Yes. The announcement highlights categories often emphasized for inclusive participation, including HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, along with faith-based/community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

Can non-U.S. (non-domestic) organizations apply?

No. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply.

Are foreign components allowed at all?

Yes. While non-U.S. entities cannot apply directly, "foreign components" (as defined by NIH in the NIH Grants Policy Statement) are allowed. This can matter for resources with legitimate international collaborations or dependencies, as long as the applicant organization is an eligible U.S. entity.

Is this opportunity limited-competition?

Yes. It is described as a limited-competition R24 opportunity intended for continuation of certain existing NIGMS-associated legacy resources at a funding transition point.

What is the funding agency and institute sponsoring the announcement?

The funding agency is the National Institutes of Health (NIH), and the sponsoring institute is the National Institute of General Medical Sciences (NIGMS).

What is the program announcement number and assistance listing/CFDA number?

The program announcement number is PAR-19-208, and the CFDA number provided is 93.859.

What category is this grant listed under?

It is described as an NIH discretionary grant opportunity in the health category.

When was this opportunity created and what was the original closing date?

The opportunity was created on March 4, 2019, and it listed an original closing date of June 14, 2019.

Is there an award ceiling or expected number of awards listed?

No. The provided details do not specify an award ceiling or the expected number of awards, which can occur in NIH program announcements where award size and count depend on application quality, program priorities, and available funds.

What is the main review emphasis suggested by the announcement details?

Based on the described expectations, the emphasis is on preserving a proven, widely valuable community resource through operational continuity (maintenance-only) and presenting a credible, realistic plan to transition the resource to long-term sustainability within the allowed three-year window.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Request for Information(RFI)

Previous opportunity: Julia Taft Refugee Fund Annual Program Statement, POL/ECON, U.S. Embassy Yaounde

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 208

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 208) also looked into and applied for these:

Funding Opportunity
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apply for PAR 19 209

Funding Number: PAR 19 209
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 013

Funding Number: RFA AG 20 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 028

Funding Number: RFA AI 19 028
Agency: National Institutes of Health
Category: Health
Funding Amount: $850,000
NINDS Institutional Research Training Program (T32) Apply for PAR 19 211

Funding Number: PAR 19 211
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) Apply for PAS 19 210

Funding Number: PAS 19 210
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA NS 19 015

Funding Number: RFA NS 19 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 19 214

Funding Number: PAR 19 214
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) Apply for PAR 19 215

Funding Number: PAR 19 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Request for Information(RFI) Apply for 72068819RFI00009

Funding Number: 72068819RFI00009
Agency: Mali USAID -Bamako
Category: Health
Funding Amount: $50,000,000
USAID Burundi Gender Based Violence (GBV) Activity Apply for RFI 695 19 GBV 00002

Funding Number: RFI 695 19 GBV 00002
Agency: Rwanda USAID-Kigali
Category: Health
Funding Amount: Case Dependent
USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity Apply for RFI 695 19 OVC 00001

Funding Number: RFI 695 19 OVC 00001
Agency: Rwanda USAID-Kigali
Category: Health
Funding Amount: Case Dependent
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) Apply for PAR 19 218

Funding Number: PAR 19 218
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maximizing Access to Research Careers (T34) Apply for PAR 19 219

Funding Number: PAR 19 219
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) Apply for PAR 19 220

Funding Number: PAR 19 220
Agency: National Institutes of Health
Category: Health
Funding Amount: $650,000
Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 PEPFAR HEALTH PARTNERS MEETING

Funding Number: 720611 PEPFAR HEALTH PARTNERS MEETING
Agency: Zambia USAID-Lusaka
Category: Health
Funding Amount: Case Dependent
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional) Apply for RFA AI 19 025

Funding Number: RFA AI 19 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) Apply for RFA AI 19 024

Funding Number: RFA AI 19 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional) Apply for RFA AI 19 015

Funding Number: RFA AI 19 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Institutional Translational Research Training Program (T32) Apply for PAR 19 228

Funding Number: PAR 19 228
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01) Apply for RFA HS 19 003

Funding Number: RFA HS 19 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 208", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: